Eurofins Scientific SE (ERF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eurofins Scientific SE (ERF) has a cash flow conversion efficiency ratio of 0.220x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€789.60 Million ≈ $923.13 Million USD) by net assets (€3.59 Billion ≈ $4.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Eurofins Scientific SE (ERF) market capitalisation for the company's overall valuation and market capitalisation.
Eurofins Scientific SE - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Eurofins Scientific SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eurofins Scientific SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eurofins Scientific SE ranked by their cash flow conversion efficiency. Explore Eurofins Scientific SE cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The AES Corporation
NYSE:AES
|
0.128x |
|
ViaSat Inc
NASDAQ:VSAT
|
0.055x |
|
APA Group
AU:APA
|
0.250x |
|
SK TELECOM CO.LTD.ADR 5/9
F:KMBA
|
0.085x |
|
Lynas Rare EARTHS Ltd
AU:LYC
|
0.025x |
|
UMB Financial Corporation
NASDAQ:UMBF
|
0.043x |
|
King Yuan Electronics Co Ltd
TW:2449
|
0.094x |
|
BALOISE HLDG AG ADR/1/10
F:BLO
|
N/A |
Annual Cash Flow Conversion Efficiency for Eurofins Scientific SE (2002–2025)
The table below shows the annual cash flow conversion efficiency of Eurofins Scientific SE from 2002 to 2025. View Eurofins Scientific SE (ERF) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.59 Billion ≈ $4.19 Billion |
€1.29 Billion ≈ $1.51 Billion |
0.361x | +47.44% |
| 2024-12-31 | €5.38 Billion ≈ $6.30 Billion |
€1.32 Billion ≈ $1.54 Billion |
0.245x | +23.62% |
| 2023-12-31 | €5.14 Billion ≈ $6.01 Billion |
€1.02 Billion ≈ $1.19 Billion |
0.198x | -15.41% |
| 2022-12-31 | €4.85 Billion ≈ $5.67 Billion |
€1.14 Billion ≈ $1.33 Billion |
0.234x | -27.44% |
| 2021-12-31 | €4.68 Billion ≈ $5.47 Billion |
€1.51 Billion ≈ $1.77 Billion |
0.323x | -1.95% |
| 2020-12-31 | €3.72 Billion ≈ $4.34 Billion |
€1.22 Billion ≈ $1.43 Billion |
0.329x | +40.74% |
| 2019-12-31 | €2.90 Billion ≈ $3.39 Billion |
€677.90 Million ≈ $792.54 Million |
0.234x | +17.07% |
| 2018-12-31 | €2.72 Billion ≈ $3.18 Billion |
€543.89 Million ≈ $635.87 Million |
0.200x | +22.41% |
| 2017-12-31 | €2.48 Billion ≈ $2.90 Billion |
€405.12 Million ≈ $473.63 Million |
0.163x | -22.89% |
| 2016-12-31 | €1.76 Billion ≈ $2.05 Billion |
€371.84 Million ≈ $434.72 Million |
0.212x | -21.46% |
| 2015-12-31 | €1.08 Billion ≈ $1.26 Billion |
€291.15 Million ≈ $340.38 Million |
0.270x | -15.63% |
| 2014-12-31 | €664.24 Million ≈ $776.57 Million |
€212.17 Million ≈ $248.05 Million |
0.319x | -25.54% |
| 2013-12-31 | €394.74 Million ≈ $461.49 Million |
€169.34 Million ≈ $197.97 Million |
0.429x | +20.27% |
| 2012-12-31 | €376.12 Million ≈ $439.73 Million |
€134.16 Million ≈ $156.85 Million |
0.357x | +3.57% |
| 2011-12-31 | €320.31 Million ≈ $374.48 Million |
€110.32 Million ≈ $128.98 Million |
0.344x | -6.46% |
| 2010-12-31 | €230.69 Million ≈ $269.70 Million |
€84.94 Million ≈ $99.30 Million |
0.368x | +16.19% |
| 2009-12-31 | €203.03 Million ≈ $237.37 Million |
€64.34 Million ≈ $75.22 Million |
0.317x | +15.65% |
| 2008-12-31 | €219.12 Million ≈ $256.17 Million |
€60.04 Million ≈ $70.19 Million |
0.274x | +49.26% |
| 2007-12-31 | €215.56 Million ≈ $252.02 Million |
€39.57 Million ≈ $46.26 Million |
0.184x | -37.57% |
| 2006-12-31 | €102.64 Million ≈ $119.99 Million |
€30.18 Million ≈ $35.28 Million |
0.294x | -4.93% |
| 2005-12-31 | €82.42 Million ≈ $96.35 Million |
€25.49 Million ≈ $29.80 Million |
0.309x | -12.53% |
| 2004-12-31 | €66.10 Million ≈ $77.28 Million |
€23.37 Million ≈ $27.32 Million |
0.354x | +44.47% |
| 2003-12-31 | €53.85 Million ≈ $62.96 Million |
€13.18 Million ≈ $15.41 Million |
0.245x | +12.56% |
| 2002-12-31 | €52.91 Million ≈ $61.86 Million |
€11.51 Million ≈ $13.45 Million |
0.217x | -- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more